By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Threshold Pharmaceuticals, Inc. 

170 Harbor Way
Suite 300
South San Francisco  California  94080-6108  U.S.A.
Phone: 650-474-8200 Fax: 650-474-2529


SEARCH JOBS


Industry
Pharmaceutical






Company News
Threshold Pharma (THLD) And Merck KGaA (MKGAF.PK), Darmstadt, Germany Agree To Key Terms For The Licensing Back Of All Rights To Evofosfamide To Threshold 1/12/2016 12:32:33 PM
Bay Area Threshold Pharma (THLD) Slashing Two-Thirds of its Workforce After Failed Trials 12/21/2015 6:33:21 AM
Threshold Pharma (THLD) Announces Its Two Phase 3 Studies Evaluating Evofosfamide Did Not Meet Primary Endpoints 12/8/2015 1:11:02 PM
Threshold Pharma (THLD) Crumbles as Merck KGaA (MKGAF.PK) Abandons Cancer Drug After Trial Failures 12/7/2015 6:00:29 AM
Threshold Pharma (THLD) Enters Into Definitive Co-Promotion Agreement For Evofosfamide With Merck KGaA (MKGAF.PK), Darmstadt, Germany 11/19/2015 12:35:08 PM
Threshold Pharma (THLD) Extends $550 Million Deal with Merck KGaA (MKGAF.PK) for 50% of Cancer Drug’s U.S. Sales 11/18/2015 5:42:55 AM
Threshold Pharmaceuticals, Inc. (THLD) Announces Presentation And Webcast At The Stifel 2015 Healthcare Conference 11/13/2015 12:44:30 PM
Threshold Pharmaceuticals, Inc. (THLD) Release: Preclinical Studies Find That Tarloxotinib May Overcome Resistance To EGFR Tyrosine Kinase Inhibitors 11/10/2015 1:03:33 PM
Threshold Pharmaceuticals, Inc. (THLD) Announces Preclinical Data On Combination Of Evofosfamide With Immune Checkpoint Inhibitors To Be Presented At The SITC 2015 Meeting 11/4/2015 10:50:46 AM
Threshold Pharmaceuticals, Inc. (THLD) Reports Third Quarter 2015 Financial And Operational Results 11/3/2015 12:46:20 PM
12345678910...
//-->